Empire Inds. (509525)
StalwartFairStock Score: 30/100 — RISKY
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 1/1
Key Financials
| Current Price | ₹1,071.45 |
| Market Cap | ₹642.87 Cr |
| P/E Ratio | 14.62 |
| ROCE | 14.36% |
| ROE | 12.11% |
| Dividend Yield | 2.77% |
| Profit Growth | 0.57% |
| Debt/Equity | — |
| Sales Growth | 7.49% |
| 52-Week Range | ₹811.05 — ₹1,145.7 |
| Sector | Diversified |
| Book Value | ₹524.59 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I look at Empire Inds. through the old lens: price, book value, earnings power, and whether the business compounds. At ₹1071.45, market cap ₹643 Cr, P/E 14.62, and P/B 2.04 against book value ₹524.59, it is not an obvious Graham bargain; I am paying nearly twice book for a diversified firm with 12.11% ROE and 14.36% ROCE. Those returns are respectable but not exceptional. Debt/equity is not available to me, so I cannot judge leverage; that is a missing piece. Growth is modest: sales up 7.49%, profit up only 0.57%, five-year revenue CAGR 8.33%. Latest quarter sales ₹189 Cr and net profit ₹11 Cr imply thin margins and no earnings momentum. The PEG of 2.54 tells me the P/E is not cheap relative to that growth. Still, Piotroski F-Score 7/9 suggests reasonable financial strength, and 2.77% dividend yield gives some cash return. The 52-week range ₹811.05–₹1145.70 shows the market has enthusiasm but also volatility. FairStock Score 30/100 (RISKY) tempers any optimism. This is a slow grower, not a fast compounder. I would want a wider margin of safety, clearer promoter and leverage data, and evidence that profit growth can catch up with revenue. Until then, it is a watchlist candidate, not a high-conviction Buffett purchase.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer